Quantcast

Latest BRCA2 Stories

2013-06-19 23:17:29

Nineteen gene panel provides the most comprehensive hereditary cancer analysis clinically available. Salt Lake City, UT (PRWEB) June 19, 2013 Ethigen announced today the US launch of their expanded BRCA1 and BRCA2 testing service, providing next-generation sequencing (NGS) and rearrangement analysis of both genes. Analysis is available individually, or as part of an expanded hereditary cancer panel, including full coverage of up to seventeen additional genes with known links to cancer risk:...

2013-06-18 19:23:17

CNIO researchers take part in an international project that describes the molecular bases of resistance to a new chemotherapeutic agent in familial breast and ovarian cancers It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumors are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2. In patients with these mutations, PARP inhibitors, which are currently in clinical trials, have shown...

2013-06-14 23:15:49

Fulgent Therapeutics, a CLIA Certified Laboratory, announces today the inclusion of BRCA1 and BRCA2 analysis into its Hereditary Cancer Panel. Temple City, CA (PRWEB) June 14, 2013 Fulgent Therapeutics LLC, a CLIA Certified Laboratory, announces the inclusion of BRCA1 and BRCA2 analysis to its Hereditary Cancer Panel. Fulgent Therapeutics is excited to add these key targets, making it the most comprehensive test for cancer risk assessment available. Fulgent Therapeutics Hereditary Cancer...

2013-06-13 23:03:37

Plaintiffs, including the American Civil Liberties Union, Association for Molecular Pathology, and American Society for Clinical Pathology, win long-fought case against Myriad Genetics, Association for Molecular Pathology v. Myriad Genetics, Inc. No. 12—398, that has far-reaching possibilities for genetic research and improved patient outcomes. Chicago, IL (PRWEB) June 13, 2013 The U.S. Supreme Court today invalidated patents on two genes associated with hereditary breast and ovarian...

Biotech Firm Loses Supreme Court Fight To Patent Human Genes
2013-06-13 12:24:31

Lawrence LeBlond for redOrbit.com - Your Universe Online A Salt Lake City, Utah-based genetics firm has lost a battle in court to keep a patent on naturally-occurring human genes. The US Supreme Court has shot down Myriad Genetics Inc.´s bid to patent breast and ovarian cancer genes, ruling that human genes cannot be patented. The decision has immediate benefits for some cancer patients but may have long-lasting repercussions for biotechnology research. The decision, written up...

2013-05-21 23:25:12

Recently, Angelina Jolie made headlines with news that she had a double mastectomy as a result of testing positive for the BRCA gene mutation, a gene that has been linked to breast and ovarian cancer. Women´s Excellence in Obstetrics and Gynecology now offers Myriad BRACAnalysis which tests for the BRCA1 & BRCA2 gene mutations. Lake Orion, Michigan (PRWEB) May 21, 2013 The star-power of Angelina Jolie is now shedding new light on BRCA gene mutations which have found to be...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.